[144] First American Financial Corporation SEC Filing
First American Financial Corporation submitted a Form 144 reporting a proposed sale of 3,500 shares of common stock through Fidelity Brokerage Services. The filing lists an aggregate market value of $229,705.35, an approximate sale date of 08/13/2025, and identifies the NYSE as the exchange with 101,800,000 shares outstanding for the issuer.
The securities were acquired via restricted stock vesting: 2,283 shares on 02/22/2023 and 1,217 shares on 02/16/2024; payment is characterized as compensation. The filer reports no securities sold in the past 3 months and includes the standard signature representation regarding undisclosed material adverse information.
First American Financial Corporation ha presentato un Modulo 144 segnalando la proposta vendita di 3,500 azioni ordinarie tramite Fidelity Brokerage Services. La comunicazione indica un valore di mercato complessivo di $229,705.35, una data di vendita approssimativa del 08/13/2025 e identifica la NYSE come il mercato, con 101,800,000 azioni in circolazione per l'emittente.
I titoli sono stati acquisiti tramite lo sblocco di azioni vincolate: 2,283 azioni il 02/22/2023 e 1,217 azioni il 02/16/2024; il pagamento è classificato come compenso. Il dichiarante riporta nessuna vendita di titoli negli ultimi 3 mesi e include la consueta dichiarazione firmata relativa all'assenza di informazioni materiali sfavorevoli non divulgate.
First American Financial Corporation presentó un Formulario 144 informando sobre la propuesta de venta de 3,500 acciones ordinarias a través de Fidelity Brokerage Services. La presentación indica un valor de mercado agregado de $229,705.35, una fecha aproximada de venta del 08/13/2025 y identifica la NYSE como la bolsa, con 101,800,000 acciones en circulación del emisor.
Los valores se adquirieron mediante el vencimiento de acciones restringidas: 2,283 acciones el 02/22/2023 y 1,217 acciones el 02/16/2024; el pago se clasifica como compensación. El presentante declara no se han vendido valores en los últimos 3 meses e incluye la representación estándar firmada respecto a la ausencia de información material adversa no divulgada.
First American Financial Corporation는 Fidelity Brokerage Services를 통해 보통주 3,500주 매도 예정임을 보고하는 Form 144를 제출했습니다. 제출서류에는 총 시가가 $229,705.35로 기재되어 있고, 매도 예정일을 08/13/2025로 표시했으며 발행사의 유통 주식 수를 101,800,000주로 하여 거래소를 NYSE로 명시했습니다.
해당 증권은 제한주식의 베스팅으로 취득되었으며: 2,283주가 02/22/2023에, 1,217주가 02/16/2024에 취득되었고 지급은 보수(보상)로 분류됩니다. 제출인은 지난 3개월 동안 증권 매도 없음을 보고했으며, 미공개된 중대한 불리한 정보가 없다는 표준 서명 진술을 포함하고 있습니다.
First American Financial Corporation a déposé un formulaire 144 signalant une vente proposée de 3,500 actions ordinaires via Fidelity Brokerage Services. Le dossier indique une valeur de marché agrégée de $229,705.35, une date approximative de vente au 08/13/2025 et identifie la NYSE comme la bourse, avec 101,800,000 actions en circulation de l'émetteur.
Les titres ont été acquis lors du vesting d'actions restreintes : 2,283 actions le 02/22/2023 et 1,217 actions le 02/16/2024 ; le paiement est qualifié de rémunération. Le déclarant indique aucun titre vendu au cours des 3 derniers mois et inclut la déclaration type signée concernant l'absence d'informations défavorables matérielles non divulguées.
First American Financial Corporation hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 3,500 Stammaktien über Fidelity Brokerage Services gemeldet wird. Die Meldung nennt einen aggregierten Marktwert von $229,705.35, ein voraussichtliches Verkaufsdatum 08/13/2025 und führt die NYSE als Börse mit 101,800,000 ausstehenden Aktien des Emittenten auf.
Die Wertpapiere wurden durch das Vesting eingeschränkter Aktien erworben: 2,283 Aktien am 02/22/2023 und 1,217 Aktien am 02/16/2024; die Zahlung wird als Vergütung eingestuft. Der Einreicher gibt an, in den letzten 3 Monaten keine Wertpapiere verkauft zu haben, und enthält die übliche unterschriebene Erklärung bezüglich nicht offengelegter wesentlicher nachteiliger Informationen.
- None.
- None.
Insights
TL;DR: This Form 144 reports a small, non‑material proposed sale relative to the issuer's outstanding shares.
The filing shows a proposed disposition of 3,500 common shares with an aggregate market value of $229,705.35. Against the stated 101,800,000 shares outstanding, the sale represents approximately 0.0034% of the outstanding shares, indicating the transaction is very small in scale. There are no reported sales in the prior three months, and the shares originated from restricted stock vesting recorded on 02/22/2023 and 02/16/2024.
TL;DR: The disclosure is routine—proceeds stem from vested compensation and the filer affirms no undisclosed material adverse information.
The Form 144 specifies that the securities to be sold were acquired through restricted stock vesting and were paid as compensation. The notice identifies the broker (Fidelity Brokerage Services LLC) and the intended exchange (NYSE), and it includes the mandatory representation regarding knowledge of material adverse information. Given the small size of the proposed sale and the absence of recent sales, this appears to be a standard insider liquidity disclosure rather than a governance red flag.
First American Financial Corporation ha presentato un Modulo 144 segnalando la proposta vendita di 3,500 azioni ordinarie tramite Fidelity Brokerage Services. La comunicazione indica un valore di mercato complessivo di $229,705.35, una data di vendita approssimativa del 08/13/2025 e identifica la NYSE come il mercato, con 101,800,000 azioni in circolazione per l'emittente.
I titoli sono stati acquisiti tramite lo sblocco di azioni vincolate: 2,283 azioni il 02/22/2023 e 1,217 azioni il 02/16/2024; il pagamento è classificato come compenso. Il dichiarante riporta nessuna vendita di titoli negli ultimi 3 mesi e include la consueta dichiarazione firmata relativa all'assenza di informazioni materiali sfavorevoli non divulgate.
First American Financial Corporation presentó un Formulario 144 informando sobre la propuesta de venta de 3,500 acciones ordinarias a través de Fidelity Brokerage Services. La presentación indica un valor de mercado agregado de $229,705.35, una fecha aproximada de venta del 08/13/2025 y identifica la NYSE como la bolsa, con 101,800,000 acciones en circulación del emisor.
Los valores se adquirieron mediante el vencimiento de acciones restringidas: 2,283 acciones el 02/22/2023 y 1,217 acciones el 02/16/2024; el pago se clasifica como compensación. El presentante declara no se han vendido valores en los últimos 3 meses e incluye la representación estándar firmada respecto a la ausencia de información material adversa no divulgada.
First American Financial Corporation는 Fidelity Brokerage Services를 통해 보통주 3,500주 매도 예정임을 보고하는 Form 144를 제출했습니다. 제출서류에는 총 시가가 $229,705.35로 기재되어 있고, 매도 예정일을 08/13/2025로 표시했으며 발행사의 유통 주식 수를 101,800,000주로 하여 거래소를 NYSE로 명시했습니다.
해당 증권은 제한주식의 베스팅으로 취득되었으며: 2,283주가 02/22/2023에, 1,217주가 02/16/2024에 취득되었고 지급은 보수(보상)로 분류됩니다. 제출인은 지난 3개월 동안 증권 매도 없음을 보고했으며, 미공개된 중대한 불리한 정보가 없다는 표준 서명 진술을 포함하고 있습니다.
First American Financial Corporation a déposé un formulaire 144 signalant une vente proposée de 3,500 actions ordinaires via Fidelity Brokerage Services. Le dossier indique une valeur de marché agrégée de $229,705.35, une date approximative de vente au 08/13/2025 et identifie la NYSE comme la bourse, avec 101,800,000 actions en circulation de l'émetteur.
Les titres ont été acquis lors du vesting d'actions restreintes : 2,283 actions le 02/22/2023 et 1,217 actions le 02/16/2024 ; le paiement est qualifié de rémunération. Le déclarant indique aucun titre vendu au cours des 3 derniers mois et inclut la déclaration type signée concernant l'absence d'informations défavorables matérielles non divulguées.
First American Financial Corporation hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 3,500 Stammaktien über Fidelity Brokerage Services gemeldet wird. Die Meldung nennt einen aggregierten Marktwert von $229,705.35, ein voraussichtliches Verkaufsdatum 08/13/2025 und führt die NYSE als Börse mit 101,800,000 ausstehenden Aktien des Emittenten auf.
Die Wertpapiere wurden durch das Vesting eingeschränkter Aktien erworben: 2,283 Aktien am 02/22/2023 und 1,217 Aktien am 02/16/2024; die Zahlung wird als Vergütung eingestuft. Der Einreicher gibt an, in den letzten 3 Monaten keine Wertpapiere verkauft zu haben, und enthält die übliche unterschriebene Erklärung bezüglich nicht offengelegter wesentlicher nachteiliger Informationen.